These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 22204487
21. TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy. Costa B, Da Pozzo E, Giacomelli C, Barresi E, Taliani S, Da Settimo F, Martini C. Sci Rep; 2016 Jan 11; 6():18164. PubMed ID: 26750656 [Abstract] [Full Text] [Related]
22. The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship. Gudasheva TA, Deeva OA, Pantileev AS, Mokrov GV, Rybina IV, Yarkova MA, Seredenin SB. Molecules; 2020 Nov 04; 25(21):. PubMed ID: 33158242 [Abstract] [Full Text] [Related]
23. Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy. Poe MM, Methuku KR, Li G, Verma AR, Teske KA, Stafford DC, Arnold LA, Cramer JW, Jones TM, Cerne R, Krambis MJ, Witkin JM, Jambrina E, Rehman S, Ernst M, Cook JM, Schkeryantz JM. J Med Chem; 2016 Dec 08; 59(23):10800-10806. PubMed ID: 27933953 [Abstract] [Full Text] [Related]
28. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands. Taliani S, Pugliesi I, Da Settimo F. Curr Top Med Chem; 2011 Dec 08; 11(7):860-86. PubMed ID: 21291396 [Abstract] [Full Text] [Related]
31. The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity. Costa B, Cavallini C, Da Pozzo E, Taliani S, Da Settimo F, Martini C. ACS Chem Neurosci; 2017 Jul 19; 8(7):1448-1454. PubMed ID: 28362078 [Abstract] [Full Text] [Related]
33. Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands. Pike VW, Taliani S, Lohith TG, Owen DR, Pugliesi I, Da Pozzo E, Hong J, Zoghbi SS, Gunn RN, Parker CA, Rabiner EA, Fujita M, Innis RB, Martini C, Da Settimo F. J Med Chem; 2011 Jan 13; 54(1):366-73. PubMed ID: 21133364 [Abstract] [Full Text] [Related]
34. Synthesis and in vitro binding of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites. Homes TP, Mattner F, Keller PA, Katsifis A. Bioorg Med Chem; 2006 Jun 01; 14(11):3938-46. PubMed ID: 16480880 [Abstract] [Full Text] [Related]
35. Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides. Barresi E, Bruno A, Taliani S, Cosconati S, Da Pozzo E, Salerno S, Simorini F, Daniele S, Giacomelli C, Marini AM, La Motta C, Marinelli L, Cosimelli B, Novellino E, Greco G, Da Settimo F, Martini C. J Med Chem; 2015 Aug 13; 58(15):6081-92. PubMed ID: 26177193 [Abstract] [Full Text] [Related]
40. Design, Synthesis and Pharmacological Activity of New Pyrrolo[1,2-A] Pyrazine Translocator Protein (TSPO) Ligands. Mokrov G, Pantileev A, Yarkova M, Gudasheva T, Seredenin S. Med Chem; 2022 Aug 13; 18(4):497-508. PubMed ID: 34365957 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]